H TALAIE
From the Shahid Beheshti University of Medical Sciences & Health Services, the WHO Collaborating Center for Educational Development of Medical & Health Personnel (EDC); and the School of Public Health, Tehran Medical Sciences University, PO. Box 6446-14155, Tehran, 1R. Iran.
[ 1 ] - CLINICAL TRIAL OF TRICLABENDAZOLE ON HUMAN FASCIOLIASIS: LONG TERM FOLLOW UP
Following an outbreak: of human fascioliasis in Gilan province of Iran in 1989, the benzimidazole derivative triclabendazole (TCBZ) was suggested as the drug of choice after finding out that routine drugs were not effective. Two studies were performed: a clinical trial (before/after type) in 1989 and a historical cohort (1989- 1995) to examine the efficacy of the drug. TCBZ was administere...
نویسندگان همکار